184 related articles for article (PubMed ID: 16688615)
1. Which triptan for which patient?
Rapoport AM; Tepper SJ; Sheftell FD; Kung E; Bigal ME
Neurol Sci; 2006 May; 27 Suppl 2():S123-9. PubMed ID: 16688615
[TBL] [Abstract][Full Text] [Related]
2. Eletriptan.
Sandrini G; Perrotta A; Tassorelli C; Nappi G
Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1587-98. PubMed ID: 19929447
[TBL] [Abstract][Full Text] [Related]
3. Almotriptan: meeting today's needs in acute migraine treatment.
Láinez MJ
Expert Rev Neurother; 2007 Dec; 7(12):1659-73. PubMed ID: 18052762
[TBL] [Abstract][Full Text] [Related]
4. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.
Winner P; Linder SL; Lipton RB; Almas M; Parsons B; Pitman V
Headache; 2007 Apr; 47(4):511-8. PubMed ID: 17445100
[TBL] [Abstract][Full Text] [Related]
5. Review of clinical trials using early acute intervention with oral triptans for migraine management.
Dowson AJ; Mathew NT; Pascual J
Int J Clin Pract; 2006 Jun; 60(6):698-706. PubMed ID: 16805756
[TBL] [Abstract][Full Text] [Related]
6. Predictors of adherence to triptans: factors of sustained vs lapsed users.
Cady RK; Maizels M; Reeves DL; Levinson DM; Evans JK
Headache; 2009 Mar; 49(3):386-94. PubMed ID: 19220501
[TBL] [Abstract][Full Text] [Related]
7. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
[TBL] [Abstract][Full Text] [Related]
8. Pathways to the best fit of triptans for migraine patients.
Buzzi MG
Cephalalgia; 2008 Sep; 28 Suppl 2():21-7. PubMed ID: 18715329
[TBL] [Abstract][Full Text] [Related]
9. Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.
Sandrini G; Dahlöf CG; Mathew N; Nappi G
Int J Clin Pract; 2005 Nov; 59(11):1356-65. PubMed ID: 16236092
[TBL] [Abstract][Full Text] [Related]
10. How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians.
Lipton RB; Cutrer FM; Goadsby PJ; Ferrari MD; Dodick DW; McCrory D; Liberman JN; Williams P
Curr Med Res Opin; 2005 Mar; 21(3):413-24. PubMed ID: 15811210
[TBL] [Abstract][Full Text] [Related]
11. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
[TBL] [Abstract][Full Text] [Related]
12. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
13. [Triptans--pivotal event in migraine treatment].
Lusić I; Bilić I
Acta Med Croatica; 2008 May; 62(2):173-8. PubMed ID: 18710081
[TBL] [Abstract][Full Text] [Related]
14. Acute migraine treatment: patterns of use and satisfaction in a clinical population.
Malik SN; Hopkins M; Young WB; Silberstein SD
Headache; 2006 May; 46(5):773-80. PubMed ID: 16643580
[TBL] [Abstract][Full Text] [Related]
15. Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy.
Goadsby PJ; Yates R
Headache; 2006 Jan; 46(1):138-49. PubMed ID: 16412161
[TBL] [Abstract][Full Text] [Related]
16. Almotriptan in triptan-naïve patients: new evidence of benefits.
Pascual J
Cephalalgia; 2008 Sep; 28 Suppl 2():14-20. PubMed ID: 18715328
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.
Allais G; Acuto G; Cabarrocas X; Esbri R; Benedetto C; Bussone G
Neurol Sci; 2006 May; 27 Suppl 2():S193-7. PubMed ID: 16688629
[TBL] [Abstract][Full Text] [Related]
18. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
[TBL] [Abstract][Full Text] [Related]
19. Oral almotriptan: practical uses in the acute treatment of migraine.
Dowson AJ
Expert Rev Neurother; 2004 May; 4(3):339-48. PubMed ID: 15853532
[TBL] [Abstract][Full Text] [Related]
20. Early triptan intervention in migraine: an overview.
Moschiano F; D'Amico D; Allais G; Rigamonti A; Melzi P; Schieroni F; Bussone G
Neurol Sci; 2005 May; 26 Suppl 2():s108-10. PubMed ID: 15926006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
